The hydrolyzed products of iridoid glycoside with β-glucosidase treatment exert anti-proliferative effects through suppression of STAT3 activation and STAT3-regulated gene products in several human cancer cells

Author： Hwang Hyundu   Kim Chulwon   Kim Sung-Moo   Kim Wan-Seok   Choi Seung-Hoon   Chang Il-Moo   Ahn Kwang Seok  

Publisher： Informa Healthcare

ISSN： 1388-0209

Source： Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol.50, Iss.1, 2012-01, pp. : 8-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Anti-proliferative Effects of Recombinant Human Lysozyme on Human Gastric Cancer Cells

By Guo TK   Zhao XH   Xie XD   Chen ZH   Zhou CS   Wei LL   Zhang H  

The Journal of International Medical Research, Vol. 35, Iss. 3, 2007-05 ,pp. : 353-360

Field House Publishing

Access to resources Recommend Favorite

STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2359-2375

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Proliferative Effects of Novel Glyco-Lipid-Arsenicals (III) on MCF-7 Human Breast Cancer Cells

By  

Medicinal Chemistry, Vol. 2, Iss. 1, 2006-01 ,pp. : 79-87

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting STAT3 in cancer: how successful are we?

By Yue Peibin   Turkson James  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 45-56

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of STAT3 for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4012-4018

Bentham Science Publishers

Access to resources Recommend Favorite